All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Selegiline transdermal system in major depressive disorder

Author(s): Ashwin A Patkar, Kimberly B Portland,Chi-Un Pae

Selegiline transdermal system (STS) has been approved to treat major depressive disorder in the USA. STS represents a novel generation of monoamine oxidase inhibitors with a superior safety profile to older monoamine oxidase inhibitors, in particular with regard to food interactions. The efficacy and safety of STS has been established in shortand long-term clinical trials. STS expands the range of pharmacological treatment options available to clinicians to treat major depressive disorder, in particular major depressive disorder with atypical features or treatment-resistant depression. This article discusses the mechanism of action of STS, summarizes efficacy and safety data from clinical trials, reviews drug and food interactions with STS and offers suggestions for use of STS in clinical practice.


PDF

Share this       

antalya escort

izmir rus escort

bursa escort bayan

antalya escort bayanlar

izmir escort

porno indir

porno izle

mobil porno

eskişehir escort

burdur escort

bartın escort

havalandırma

türk takipçi satın al

smmabi.com

takipbonus.com

izmir escort

bursa escort

türk porno

escort bayan

yabanci porno

takipçi satın al

takipçi satın al

instagram takipçi satın al

instagram beğeni satın al

instagram takipçi kazan

takipçi satın al

instagram takipçi satın al

smm panel

instagram takipçi satın al

takipçi satın al

takipçi satın al

takipçi satın al

takipçi satın al

instagram takipçi hilesi

tiktok takipçi hilesi

türk takipçi satın al

takipçi satın al spotify

tiktok takipçi satın alma

ucuz takipçi satın al

tiktok takipçi satın al

instagram unfollow

paper io

agario

oversatt

Elektronik Sigara